Cost of Illness Pasien Hipertensi Rawat Inap di RSUP Prof. Dr. R. D. Kandou Manado
DOI:
https://doi.org/10.35790/ecl.v12i3.58444Abstract
Abstract: Besides causing systemic damage to organs, hypertensive disease also has an impact on the health economy sector (double burden disease). This study aimed to determine the cost of illness of hypertensive inpatients and its suitability with INA-CBG's tariff. This was an analytical and observational study with a cross-sectional designh. Data were collected retrospectively from the medical records of hypertensive inpatients registered as members of Jaminan kesehatan Nasional (National Health Insurance) from January to June 2024 and from financial department of Prof. Dr. R. D. Kandou Hospital Manado. Pharmaeconomic analysis was used based on hospital perspective and prevalence approach. The data were analyzed using one sample t-test to compare the congruence between cost of illness and INA-CBG’s tariff. There were 30 inpatients in this study, consisting of 10 males and 21 females. The results showed that the difference between total cost of illness and INA-CBG’s tariff was Rp.76,403,811. The one sample t-test showed that the congruence between cost of illness and INA-CBG’s tariff was significantly different based on the p-values of each code, as follows: 0.001 (I-17-14-I), 0.000 (I-17-14-II), and 0.000 (I-17-14-III). In conclusion, the total cost of illness of hypertensive inpatients at Prof. Dr. R. D. Kandou Hospital was Rp. 251,287,311 with an average per patient of Rp. 8,376,244. Moreover, overall there is a significant difference between cost of illness and INA-CBG's tariff.
Keywords: cost of illness; hypertensive inpatients; Indonesian Case-based Group
Abstrak: Penyakit hipertensi bukan hanya menyebabkan kerusakan sistemik di organ namun juga berdampak pada sektor ekonomi kesehatan (double burden disease). Penelitian ini bertujuan untuk mengetahui besaran terapi pasien hipertensi (cost of illness) dan kesesuaiannya dengan tarif INA-CBG’s. Jenis penelitian ialah observasional analitik dengan desain potong lintang. Data pasien hipertensi Jaminan kesehatan Nasional (JKN) rawat inap diperoleh secara retrospektif dari Bagian Rekam Medik dan Bagian Keuangan RSUP Prof. Dr. R. D. Kandou Manado periode Januari-Juni 2024. Analisis farmakoekonomi dilakukan dengan kajian berdasarkan perspektif rumah sakit dimana kategori biaya dalam perhitungan cost of illness menggunanakan biaya medis langsung dengan pendekatan secara prevalensi. Data analisis uji beda menggunakan one sample t-test untuk mengetahui perbandingan biaya cost of illness dengan tarif INA-CBG’s. Hasil penelitian mendapatkan 30 pasien sebagai sampel, terdiri dari 10 laki-laki dan 21 perempuan. Besaran selisih antara cost of illness dengan tarif INA-CBG’s sebesar Rp. 76.403.811. Kesesuaian antara cost of illness dengan tarif INA-CBG’s menggunakan one sample t-test berbeda bermakna dengan nilai p masing-masing kode ialah 0,001 (I-17-14-I); 0,000 (I-17-14-II); dan 0,000 (I-17-14-III). Simpulan penelitian ini ialah total cost of illness pasien hipertensi rawat inap RSUP Prof Dr. R. D. Kandou sebesar Rp. 251.287.311 dengan rerata per pasien sebesar Rp. 8.376.244. Terdapat perbedaan bermakna antara cost of illness dan tarif INA-CBG’s.
Kata kunci: cost of illness; pasien hipertensi; Indonesian Case-based Group
References
Hou HJ, Cong TZ, Cai Y, Ba YH, Chen MeE, Yang JY, et al. Influencing factors of hospitalization cost of hypertension patients in traditional Chinese medicine hospitals. Front Public Health. 2024;12 (1329768):1-12. Doi: 10.3389/fpubh.2024.1329768
Sorato MM, Davari M, Kebriaeezadeh A, Sarrafzadegan N, Shibru T. Societal economic burden of hypertension at selected hospitals in southern Ethiopia: a patient-level analysis. BMJ Open. 2022; 12(4):1-13. Doi: 10.1136/bmjopen-2021-056627
Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2224–60. Doi: 10.1016/S0140-6736(12)61766-8
Rosiyani EA, Witcahyo E, Herawati YT. Perhitungan cost of illness (COI) pasien hipertensi di pelayanan rawat inap RSD Balung Kabupaten Jember Cost of illness of hypertension inpatients in RSD Balung Kabupaten Jember. Jurnal Ilmu Kesehatan Masyarakat Berkala. 2021;3(2):117–22. Doi: https://doi.org/10.32585/jikemb.v3i2.1873
Nilansari AF, Yasin NM, Puspandari DA. Analisis tarif INA-CBGs pasien hipertensi rawat inap di Rumah Sakit Umum Daerah Panembahan Senopati. Indonesian Journal of Clinical Pharmacy. 2021;10(1): 22-9 Doi: https://doi.org/10.15416/ijcp.2021.10.1.22
Manawan F, Widodo GP, Andayani TM. Cost of illness pasien kanker payudara di RSUP Prof. Dr. R. D. Kandou Manado. Pharmacy Medical Journal. 2019;2(2):86–93. Doi: https://doi.org/10.35799/pmj.2.2.2019.26532
Trias E, Prostianty L, Hidayati IR. Analisis cost-of-illness pada pasien hipertensi peserta BPJS Rawat Jalan di Puskesmas Banyuanyar. Pharmaceutical Journal of Indonesia. 2020;6(1):41-6. Doi:10.21776/ub. pji.2020.006.01.7
Kementerian Kesehatan Republik Indonesia. 2023. Permenkes Nomor 3 Tahun 2023 tentang Standar Tarif Pelayanan Kesehatan dalam Penyelenggaraan Prgram Jaminan Kesehatan.
Baroroh F, Maghfiroh R. direct medical cost and length of stay of hypertension patients at private hospital in Yogyakarta. Jurnal Farmasi Sains dan Praktis. 2023;9 (1):27–33. Doi:10.31603/pharmacy.v9i1.6925
Purwidyaningrum I, Sunarni T. Analisis biaya riil pengobatan pasien hipertensi rawat inap terhadap tarif INA-CBG’s di RSNU Jombang. Medical Sains. 2020;7(4):881-90. Doi:10.37874/ms.v7i4.507
Gultom R, Silvia M. Cost minimalization analysis (CMA) penggunaan obat antihipertensi golongan calcium channel blocker kombinasi angiotensin receptor blocker pada pasien hipertensi di RSU Imelda Pekerja Indonesia Medan. Jurnal Ilmiah Farmasi Imelda (JIFI). 2022;5(2):51-6. Doi: 10.52943/ jifarmasi.v5i2.771
Fadillah A, Ramadhani J, Erlianti K, Hasniah D. Analisis cost of illness penyakit hipertensi di Rumah Sakit Umum Daerah Praya, NTB. Al Ulum. 2021;6(2):104-11. Doi:10.31602/ajst.v6i2.5226
Mashuri YA, Ng N, Santosa A. Socioeconomic disparities in the burden of hypertension among Indonesian Adults - a multilevel analysis. Global Health Action. 2022;15(1):1-10. Doi: https://doi.org/10.1080/ 16549716.2022.2129131
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Widya A. Lolo, Weny I. Wiyono, Deby A. Mpila
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
COPYRIGHT
Authors who publish with this journal agree to the following terms:
Authors hold their copyright and grant this journal the privilege of first publication, with the work simultaneously licensed under a Creative Commons Attribution License that permits others to impart the work with an acknowledgment of the work's origin and initial publication by this journal.
Authors can enter into separate or additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (for example, post it to an institutional repository or publish it in a book), with an acknowledgment of its underlying publication in this journal.
Authors are permitted and encouraged to post their work online (for example, in institutional repositories or on their website) as it can lead to productive exchanges, as well as earlier and greater citation of the published work (See The Effect of Open Access).
